Special Session

Workshop 03 - ASTRO Theranostics Training Course: Expand Your Practice into Radiopharmaceuticals

1:00 PM - 4:00 PM
Location: Room W184

Session Type: Workshop
3.00 AMA PRA Category 1 Credits™
3.00 CAMPEP Credits
3.00 MDCB Credits

Many new radiopharmaceutical therapies (RPTs) are now approved and many others are emerging for treatment of prostate cancer, neuroendocrine cancers and other cancers. Radiation oncologists are experts regarding the benefits and risks associated with various cancer therapeutic options and are perfectly positioned to help patients make the best choice for their particular situation, including the use of RPT's. Radiation oncologists are certified to deliver these RPTs but many lack specific and updated training and therefore underutilize them. This ? day training course is designed to teach clinical radiation oncologists everything they need to know to expand their practice into radiopharmaceutical therapy. It will provide a refresher on relevant physics, pharmacology, and radiobiology, as well as offer logistical and practical training in clinical use of radiopharmaceuticals. It will include specific breakout sessions on Ra-223, Lu-177 DOTATATE, Lu-177 PSMA agents, I-131 MIBG and Y-90 Microspheres. It will also cover important infrastructure, workflow and financial considerations. This special training course will enable radiation oncologists to provide the highest quality of patient-centered care in the use of RPTs.


Ana Kiess, MD, PhD

Johns Hopkins University


Send Email for Ana Kiess

John Buatti, MD, FASTRO

University of Iowa

John M. Buatti, MD, FASTRO, Professor and Chair, Department of Radiation Oncology, University of Iowa

Dr. Buatti is Professor and the Chair of the Department of Radiation Oncology, a position that he has held with distinction since 2001 when he established an independent department at the University of Iowa Hospitals and Clinics. In 2005, he opened Iowa’s first Center of Excellence in Image Guided Radiation Therapy, which was innovative for its use of advanced 3D imaging including a 3T MR scanner and 40 slice respiratory-gated PET/CT scanner to better locate and treat tumors. As a clinician, he is a leading authority on the treatment of cranial malignancies.
He is a prolific scholar having authored or co-authored more than 220 peer-reviewed publications. He has published 24 book chapters, and more than 170 abstracts.
With a life-long commitment to improve the quality of cancer imaging he served as the first chair of the Steering Committee for the Quantitative Imaging Network (QIN) and Chair of the Clinical Trials Design and Development Working Group and was a member of the Coordinating Committee for QIN. He has served on the ASTRO Education Committee, as Co-Chair of the ASTRO IHE-RO (Integrating Health Enterprise-Radiation Oncology) and served on the ASTRO Science Council Steering Committee. He is currently chairing an ASTRO task-force on Theranostics as well as a member of the ASTRO Nominating Committee.
He is and advocate for diversity in the workplace and encourages the development of scientist-investigators through summer internships and the active recruitment of minorities. His enthusiastic devotion to education is evident in his biography.


Send Email for John Buatti


Workshop 03 - ASTRO Theranostics Training Course: Expand Your Practice into Radiopharmaceuticals

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Workshop 03 - ASTRO Theranostics Training Course: Expand Your Practice into Radiopharmaceuticals